NL192870C - Anti-hypertensief oraal farmaceutisch preparaat. - Google Patents
Anti-hypertensief oraal farmaceutisch preparaat. Download PDFInfo
- Publication number
- NL192870C NL192870C NL7812164A NL7812164A NL192870C NL 192870 C NL192870 C NL 192870C NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A NL 192870 C NL192870 C NL 192870C
- Authority
- NL
- Netherlands
- Prior art keywords
- day
- hydrochlorothiazide
- blood pressure
- hours
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86442877A | 1977-12-27 | 1977-12-27 | |
US86442877 | 1977-12-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7812164A NL7812164A (nl) | 1979-06-29 |
NL192870B NL192870B (nl) | 1997-12-01 |
NL192870C true NL192870C (nl) | 1998-04-02 |
Family
ID=25343256
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7812164A NL192870C (nl) | 1977-12-27 | 1978-12-14 | Anti-hypertensief oraal farmaceutisch preparaat. |
NL980017C NL980017I1 (nl) | 1977-12-27 | 1998-04-24 | Anti-hypertensief oraal farmaceutisch preparaat. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL980017C NL980017I1 (nl) | 1977-12-27 | 1998-04-24 | Anti-hypertensief oraal farmaceutisch preparaat. |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS54110333A (ja) |
AR (1) | AR230378A1 (ja) |
AU (1) | AU526239B2 (ja) |
BE (1) | BE873092A (ja) |
CA (1) | CA1120400A (ja) |
CH (1) | CH642542A5 (ja) |
DE (1) | DE2854316C3 (ja) |
DK (1) | DK578778A (ja) |
EG (1) | EG14178A (ja) |
FI (1) | FI783991A (ja) |
FR (1) | FR2413089A1 (ja) |
GB (1) | GB2010675B (ja) |
GR (1) | GR72951B (ja) |
HK (1) | HK45483A (ja) |
HU (1) | HU178747B (ja) |
IE (1) | IE48306B1 (ja) |
IL (1) | IL56281A (ja) |
IT (1) | IT1202811B (ja) |
KE (1) | KE3235A (ja) |
LU (1) | LU80709A1 (ja) |
MY (2) | MY8300240A (ja) |
NL (2) | NL192870C (ja) |
NO (1) | NO784357L (ja) |
NZ (1) | NZ189159A (ja) |
PH (1) | PH22111A (ja) |
PL (1) | PL212188A1 (ja) |
PT (1) | PT68983A (ja) |
SE (1) | SE445173B (ja) |
SG (1) | SG41482G (ja) |
ZA (1) | ZA786948B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5829950B2 (ja) * | 1978-10-05 | 1983-06-25 | ウェルファイド株式会社 | 環状イミノカルボン酸誘導体およびその塩類 |
US4350704A (en) | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
US4482725A (en) * | 1980-04-03 | 1984-11-13 | E. R. Squibb & Sons, Inc. | S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics |
US4344949A (en) | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
US4532342A (en) * | 1981-02-20 | 1985-07-30 | Warner-Lambert Company | N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
US4552889A (en) * | 1983-06-09 | 1985-11-12 | Eli Lilly And Company | 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension |
US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
DE3532036A1 (de) * | 1985-09-09 | 1987-03-26 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des bluthochdrucks |
DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
AU4777896A (en) * | 1995-02-10 | 1996-08-27 | G.D. Searle & Co. | Use of low dose amount of spironolactone for treatment of cardiovascular disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU509899B2 (en) * | 1976-02-13 | 1980-05-29 | E.R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
-
1978
- 1978-11-21 CA CA000316609A patent/CA1120400A/en not_active Expired
- 1978-11-29 AU AU42041/78A patent/AU526239B2/en not_active Expired
- 1978-12-06 FR FR7834359A patent/FR2413089A1/fr active Granted
- 1978-12-06 IE IE2413/78A patent/IE48306B1/en unknown
- 1978-12-12 ZA ZA786948A patent/ZA786948B/xx unknown
- 1978-12-13 NZ NZ189159A patent/NZ189159A/en unknown
- 1978-12-14 CH CH1273778A patent/CH642542A5/de not_active IP Right Cessation
- 1978-12-14 NL NL7812164A patent/NL192870C/nl not_active IP Right Cessation
- 1978-12-14 GR GR57879A patent/GR72951B/el unknown
- 1978-12-15 DE DE2854316A patent/DE2854316C3/de not_active Expired - Lifetime
- 1978-12-19 PH PH21971A patent/PH22111A/en unknown
- 1978-12-21 GB GB7849703A patent/GB2010675B/en not_active Expired
- 1978-12-22 NO NO784357A patent/NO784357L/no unknown
- 1978-12-22 HU HU78SU1000A patent/HU178747B/hu unknown
- 1978-12-22 SE SE7813277A patent/SE445173B/sv not_active IP Right Cessation
- 1978-12-22 IL IL56281A patent/IL56281A/xx unknown
- 1978-12-22 DK DK578778A patent/DK578778A/da not_active Application Discontinuation
- 1978-12-22 IT IT31266/78A patent/IT1202811B/it active Protection Beyond IP Right Term
- 1978-12-22 LU LU80709A patent/LU80709A1/de unknown
- 1978-12-25 JP JP16462778A patent/JPS54110333A/ja active Granted
- 1978-12-25 EG EG740/78A patent/EG14178A/xx active
- 1978-12-26 PT PT68983A patent/PT68983A/pt unknown
- 1978-12-27 FI FI783991A patent/FI783991A/fi unknown
- 1978-12-27 BE BE192574A patent/BE873092A/xx not_active IP Right Cessation
- 1978-12-27 AR AR274975A patent/AR230378A1/es active
- 1978-12-27 PL PL21218878A patent/PL212188A1/xx unknown
-
1982
- 1982-09-02 SG SG414/82A patent/SG41482G/en unknown
- 1982-09-14 KE KE3235A patent/KE3235A/xx unknown
-
1983
- 1983-10-20 HK HK454/83A patent/HK45483A/xx not_active IP Right Cessation
- 1983-12-30 MY MY240/83A patent/MY8300240A/xx unknown
-
1987
- 1987-10-31 MY MYPI87003001A patent/MY102991A/en unknown
-
1998
- 1998-04-24 NL NL980017C patent/NL980017I1/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100448439C (zh) | 用于头痛、偏头痛、恶心和呕吐的药物组合物 | |
US4217347A (en) | Method of treating hypertension and medicaments therefor | |
NL192870C (nl) | Anti-hypertensief oraal farmaceutisch preparaat. | |
CZ177397A3 (en) | Use of frank incense for preparing a medicament for prophylactic and therapeutic treatment of alzheimer's disease | |
Plänitz | Comparison of moxonidine and clonidine HCl in treating patients with hypertension | |
EP0629400B1 (en) | Idebenone compositions for treating Alzheimer's disease | |
WO2001056609A1 (de) | Pharmazeutische zusammensetzung für die behandlung einer durch arzneimittel induzierten hyperhomocysteinämie | |
DE69712338T2 (de) | Zusammensetzung auf basis von enalapril und losartan | |
EP0005015A1 (en) | Use of a xanthine derivate in the manufacture of a medicament | |
CN105407876B (zh) | 抗结核病的稳定的包含异烟肼颗粒和利福喷汀颗粒的可分散的片剂及其制备方法 | |
CA2870373A1 (en) | Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof | |
US4225607A (en) | Pharmaceutical composition containing a xanthine derivative | |
DK165966B (da) | Forbedret piroxicamholdigt anti-inflammatorisk praeparat | |
JPS626687B2 (ja) | ||
JP2584636B2 (ja) | 胃炎治療剤 | |
DE3888827T2 (de) | Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan. | |
JP3024789B2 (ja) | 血圧降下剤 | |
Wiseman et al. | Development of a sustained‐release aspirin tablet | |
JPH0251885B2 (ja) | ||
EP0576452B1 (de) | Erzeugnisse, enthaltend verapamil und trandolapril | |
KR20010019397A (ko) | 발기부전 치료용 조성물 | |
GB2141027A (en) | Diltiazem hypolipidemic compositions | |
DE68912159T2 (de) | Dioxoquinazolinderivat enthaltendes Antihypertensivum. | |
JPS58140017A (ja) | 心不全治療剤 | |
JPS5852220A (ja) | 血清尿酸値低下剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
AC1 | Application for a supplementary protection certificate |
Free format text: 980017, 980424 |
|
BC1 | Further communications concerning applications for a supplementary protection certificate |
Free format text: 980017 |
|
BC1 | Further communications concerning applications for a supplementary protection certificate |
Free format text: 980017 |
|
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 981214 |